Skip to content

A Post Market Surveillance Study About the MONOCER Cup

Monocer Cup: Open, Prospective, Multicentric, Non Randomised Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05785364
Enrollment
250
Registered
2023-03-27
Start date
2022-01-25
Completion date
2050-02-01
Last updated
2024-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Hip Arthroplasty

Brief summary

Over the years, the use of large diameter femoral heads has become increasingly common in orthopaedics due to the decreased risk of dislocation due to increased jumping distance and range of motion. The history of total hip arthroplasty does not favour large diameter heads, especially as conventional polyethylene has a high risk of wear. The development of hard-on-hard bearings (CoC) with a second generation ceramic material and the introduction of cross-linked PE have led to the reintroduction of this concept. The Mpact 3D Metal MonoCER cup was developed to offer the advantages of accommodating large diameter heads with an external metal cup with a pre-assembled system that avoids the surgical step of insert-cotile coupling.

Detailed description

All patients candidated to receive a total hip arthroplasty under 75 years old, who will receive a Mpact 3D Metal cup will be proposed to take part to the study. They will receive the same treatment in case they will not partecipate; the study is an observational study according to standard practice. The study aim to assess the long term peformance of the cup at 10 years after surgery. The patients will be visited at 6 months, 1, 5 and 10 years after surgery.

Interventions

DEVICEMpact 3D metal MONOCER cup

adult patients requiring a total hip arthroplasty under 75 years old, will receive the Mpact 3D metal cup, as acetabular sheel device implanted

Sponsors

Medacta International SA
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Patients undergoing total hip arthroplasty who will receive the Mpact 3D Metal MonoCER acetabular component according to the instructions for use 2. Patients who have signed the informed consent to participate in the study

Exclusion criteria

1. Minor patients, patients over 75 years of age at the time of primary surgery; 2. Any patient who is unable or unwilling to give informed consent to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Assessment of implant survivorship using Kaplan Meier curve10 yearsa Kaplan Meir survival curve will be calcuated

Secondary

MeasureTime frameDescription
Assessment of Device stability throught a radiological exam6 months, 1 year, 5 and 10 yearsstandard x-ray examination will be peformed during the visits
Assessment of the clinical outcome following total hip replacement using the Harris Hip score6 months, 1 year, 5 and 10 yearsHHS score will be completed
Device Safety assessed through adverse event collectionup to 10 yrs follow-upnumber of adverse event occurred

Countries

Switzerland

Contacts

Primary ContactElisa Bonacina, PhD
bonacina@medacta.ch+41 91 696 60 60

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026